MUC1 靶向 CAR-T 细胞分泌的抗 PD-1 IgG 抗体增强胆管癌的抗肿瘤活性

MUC1-targeted CAR-T cell secreted anti-PD-1 IgG antibody enhances antitumor activity in Cholangiocarcinoma.

推进胆管癌诊疗：T 细胞治疗的见解与创新

Advancing Cholangiocarcinoma Care: Insights and Innovations in T Cell Therapy.

用于肝内胆管癌治疗的靶向 MUC1 肿瘤相关糖型工程化 CAR-T 细胞开发

Development of Engineered CAR T Cells Targeting Tumor-Associated Glycoforms of MUC1 for the Treatment of Intrahepatic Cholangiocarcinoma.

表达 PD-1-CD28 转换受体的抗黏蛋白 1 CAR-T 细胞对胆管癌细胞的细胞毒活性

Cytotoxic activity of anti-mucin 1 chimeric antigen receptor T cells expressing PD-1-CD28 switch receptor against cholangiocarcinoma cells.

M.CAR/SR T 细胞的细胞毒性功能较 M.CAR-T 细胞增强，有望进一步用于 CCA 治疗的测试。